Frameshift mutations (Fsindel) complement tumor mutation burden (TMB) in predicting survival after immune checkpoint inhibitors (ICI) in a pancancer analysis Meeting Abstract


Authors: Florou, V.; Park, W.; Hosein, P. J.; Wilky, B. A.; Trent, J. C.; Lopes, G.
Abstract Title: Frameshift mutations (Fsindel) complement tumor mutation burden (TMB) in predicting survival after immune checkpoint inhibitors (ICI) in a pancancer analysis
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 134s
Language: English
ACCESSION: WOS:000487345804565
DOI: 10.1200/JCO.2019.37.15_suppl.2617
PROVIDER: wos
Notes: Meeting Abstract: 2617 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wungki Park
    98 Park